Amgen Inc. DEF 14A: Executive Compensation Details Revealed
Ticker: AMGN · Form: DEF 14A · Filed: 2024-04-17T00:00:00.000Z
Sentiment: neutral
Topics: executive-compensation, proxy-statement, sec-filing
Related Tickers: AMGN
TL;DR
Amgen's 2023 exec pay details out in DEF 14A - stock/option awards and fair value changes highlighted.
AI Summary
Amgen Inc. filed its DEF 14A on April 17, 2024, detailing executive compensation for the fiscal year ending December 31, 2023. The filing includes information on stock and option awards, as well as year-over-year changes in the fair value of these awards for both PEO and non-PEO members. Specific compensation details for executives like the CEO, Chief Financial Officer, and Chief Scientific Officer are presented in tables.
Why It Matters
This filing provides transparency into how Amgen Inc. compensates its top executives, which can influence investor perception and corporate governance.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures of executive compensation and corporate governance, but can sometimes reveal information that impacts stock price or regulatory scrutiny.
Key Numbers
- 2023 — Fiscal Year (Executive compensation data pertains to this year.)
- 20240417 — Filing Date (Date the DEF 14A was submitted to the SEC.)
Key Players & Entities
- AMGEN INC (company) — Filer
- 0000318154 (company) — Central Index Key
- 20240417 (date) — Filing Date
- 2023-12-31 (date) — Fiscal Year End
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit shareholder votes on important corporate matters, including the election of directors and executive compensation.
When did Amgen Inc. file this DEF 14A?
Amgen Inc. filed this DEF 14A on April 17, 2024.
What fiscal year does the compensation information in this filing primarily cover?
The compensation information in this filing primarily covers the fiscal year ending December 31, 2023.
What types of compensation are detailed for executives in this filing?
The filing details stock awards, option awards, and changes in the fair value of these awards, including year-over-year increases or decreases for both PEO and non-PEO members.
Where is Amgen Inc. headquartered?
Amgen Inc. is headquartered at One Amgen Center Drive, Thousand Oaks, CA 91320.
From the Filing
0001193125-24-099062.txt : 20240417 0001193125-24-099062.hdr.sgml : 20240417 20240417160224 ACCESSION NUMBER: 0001193125-24-099062 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 83 CONFORMED PERIOD OF REPORT: 20240531 FILED AS OF DATE: 20240417 DATE AS OF CHANGE: 20240417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37702 FILM NUMBER: 24850953 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 DEF 14A 1 d445034ddef14a.htm DEF 14A DEF 14A DEF 14A false 0000318154 0000318154 2023-01-01 2023-12-31 0000318154 2021-01-01 2021-12-31 0000318154 2020-01-01 2020-12-31 0000318154 2022-01-01 2022-12-31 0000318154 amgn:SummaryCompensationTableValueOfOptionAwardsMember ecd:PeoMember 2020-01-01 2020-12-31 0000318154 amgn:SummaryCompensationTableValueOfStockAwardsMember ecd:PeoMember 2020-01-01 2020-12-31 0000318154 amgn:IncreaseDecreaseFromPriorYearEndInFairValueOfAwardsThatVestedDuringTheYearMember ecd:PeoMember 2020-01-01 2020-12-31 0000318154 amgn:YearOverYearIncreaseDecreaseInFairValueAsOfYearEndOfUnvestedAwardsGrantedInPriorYearsMember ecd:PeoMember 2020-01-01 2020-12-31 0000318154 amgn:FairValueAsOfYearEndOfEquityAwardsGrantedDuringTheYearMember ecd:PeoMember 2020-01-01 2020-12-31 0000318154 amgn:IncreaseDecreaseFromPriorYearEndInFairValueOfAwardsThatVestedDuringTheYearMember ecd:NonPeoNeoMember 2020-01-01 2020-12-31 0000318154 amgn:YearOverYearIncreaseDecreaseInFairValueAsOfYearEndOfUnvestedAwardsGrantedInPriorYearsMember ecd:NonPeoNeoMember 2020-01-01 2020-12-31 0000318154 amgn:FairValueAsOfYearEndOfEquityAwardsGrantedDuringTheYearMember ecd:NonPeoNeoMember 2020-01-01 2020-12-31 0000318154 amgn:SummaryCompensationTableValueOfOptionAwardsMember ecd:NonPeoNeoMember 2020-01-01 2020-12-31 0000318154 amgn:SummaryCompensationTableValueOfStockAwardsMember ecd:NonPeoNeoMember 2020-01-01 2020-12-31 0000318154 amgn:SummaryCompensationTableValueOfOptionAwardsMember ecd:PeoMember 2021-01-01 2021-12-31 0000318154 amgn:SummaryCompensationTableValueOfStockAwardsMember ecd:PeoMember 2021-01-01 2021-12-31 0000318154 amgn:IncreaseDecreaseFromPriorYearEndInFairValueOfAwardsThatVestedDuringTheYearMember ecd:NonPeoNeoMember 2021-01-01 2021-12-31 0000318154 amgn:YearOverYearIncreaseDecreaseInFairValueAsOfYearEndOfUnvestedAwardsGrantedInPriorYearsMember ecd:NonPeoNeoMember 2021-01-01 2021-12-31 0000318154 amgn:FairValueAsOfYearEndOfEquityAwardsGrantedDuringTheYearMember ecd:NonPeoNeoMember 2021-01-01 2021-12-31 0000318154 amgn:SummaryCompensationTableValueOfOptionAwardsMember ecd:NonPeoNeoMember 2021-01-01 2021-12-31 0000318154 amgn:IncreaseDecreaseFromPriorYearEndInFairValueOfAwardsThatVestedDuringTheYearMember ecd:PeoMember 2021-01-01 2021-12-31 0000318154 amgn:YearOverYearIncreaseDecreaseInFairValueAsOfYearEndOfUnvestedAwardsGrantedInPriorYearsMember ecd:PeoMember 2021-01-01 2021-12-31 0000318154 amgn:FairValueAsOfYearEndOfEquityAwardsGrantedDuringTheYearMember ecd:PeoMember 2021-01-01 2021-12-31 0000318154 amgn:SummaryCompensationTableValueOfStockAwardsMember ecd:NonPeoNeoMember 2021-01-01 2021-12-31 0000318154 amgn:IncreaseDecreaseFromPriorYearEndInFairValueOfAwardsThatVestedDuringTheYearMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0000318154 amgn:YearOverYearIncreaseDecreaseInFairValueAsOfYearEndOfUnvestedAwardsGrantedInPriorYearsMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0000318154 amgn:FairValueAsOfYearEndOfEquityAwardsGrantedDuringTheYearMember ecd:NonPeoNeoMember 2022-01-01 2022-12-31 000031